ALLOGENE THERAPEUTICS Trademark

Trademark Overview

On Friday, September 28, 2018, a trademark application was filed for ALLOGENE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALLOGENE THERAPEUTICS trademark a serial number of 88136819. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by Allogene Therapeutics, Inc.. The ALLOGENE THERAPEUTICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment
allogene therapeutics

General Information

Serial Number88136819
Word MarkALLOGENE THERAPEUTICS
Filing DateFriday, September 28, 2018
Status700 - REGISTERED
Status DateTuesday, June 1, 2021
Registration Number6373408
Registration DateTuesday, June 1, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesProviding medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 6, 2018
Primary Code044
First Use Anywhere DateSaturday, December 5, 2020
First Use In Commerce DateSaturday, December 5, 2020

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, April 28, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 27, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 7, 2021USE AMENDMENT FILED
Wednesday, April 21, 2021EXTENSION 4 GRANTED
Wednesday, April 7, 2021EXTENSION 4 FILED
Wednesday, April 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 7, 2021TEAS EXTENSION RECEIVED
Wednesday, April 7, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2020EXTENSION 3 GRANTED
Friday, September 18, 2020EXTENSION 3 FILED
Friday, September 18, 2020TEAS EXTENSION RECEIVED
Thursday, April 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 31, 2020EXTENSION 2 GRANTED
Tuesday, March 31, 2020EXTENSION 2 FILED
Tuesday, March 31, 2020TEAS EXTENSION RECEIVED
Thursday, October 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 22, 2019EXTENSION 1 GRANTED
Tuesday, October 22, 2019EXTENSION 1 FILED
Tuesday, October 22, 2019TEAS EXTENSION RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 18, 2019ASSIGNED TO LIE
Tuesday, January 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 1, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, January 1, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 1, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, January 1, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 26, 2018ASSIGNED TO EXAMINER
Saturday, October 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 2, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics allogene medical field immunotherapy treatment reports cancer form information patients professionals